Arete Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $557K | Sell |
7,967
-149
| -2% | -$10.4K | 0.04% | 379 |
|
|
2025
Q1 | $597K | Sell |
8,116
-358
| -4% | -$26.3K | 0.05% | 343 |
|
|
2024
Q4 | $555K | Buy |
8,474
+4,200
| +98% | +$275K | 0.04% | 383 |
|
|
2024
Q3 | $333K | Sell |
4,274
-7,346
| -63% | -$572K | 0.03% | 490 |
|
|
2024
Q2 | $906K | Buy |
11,620
+630
| +6% | +$49.1K | 0.07% | 258 |
|
|
2024
Q1 | $745K | Sell |
10,990
-116
| -1% | -$7.86K | 0.07% | 250 |
|
|
2023
Q4 | $748K | Buy |
11,106
+306
| +3% | +$20.6K | 0.06% | 311 |
|
|
2023
Q3 | $731K | Buy |
10,800
+299
| +3% | +$20.2K | 0.13% | 176 |
|
|
2023
Q2 | $752K | Sell |
10,501
-148
| -1% | -$10.6K | 0.07% | 274 |
|
|
2023
Q1 | $739K | Sell |
10,649
-1,573
| -13% | -$109K | 0.06% | 267 |
|
|
2022
Q4 | $829M | Buy |
12,222
+1,251
| +11% | +$84.8M | 0.07% | 234 |
|
|
2022
Q3 | $602K | Buy |
+10,971
| New | +$602K | 0.06% | 266 |
|
|
2022
Q2 | – | Sell |
-5,965
| Closed | -$396K | – | 459 |
|
|
2022
Q1 | $396K | Sell |
5,965
-202
| -3% | -$13.4K | 0.03% | 336 |
|
|
2021
Q4 | $359K | Buy |
+6,167
| New | +$359K | 0.03% | 349 |
|
|
2020
Q4 | – | Sell |
-6,113
| Closed | -$331K | – | 405 |
|
|
2020
Q3 | $331K | Sell |
6,113
-9,361
| -60% | -$507K | 0.05% | 276 |
|
|
2020
Q2 | $818K | Buy |
15,474
+9,944
| +180% | +$526K | 0.14% | 166 |
|
|
2020
Q1 | $247K | Buy |
5,530
+41
| +0.7% | +$1.83K | 0.05% | 276 |
|
|
2019
Q4 | $274K | Sell |
5,489
-80
| -1% | -$3.99K | 0.05% | 314 |
|
|
2019
Q3 | $248K | Buy |
+5,569
| New | +$248K | 0.05% | 330 |
|